Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
immunomedics
indiana blog main
indiana top stories
life sciences
national
national blog main
2
×
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
2
×
vc
wisconsin blog main
wisconsin top stories
2
×
accent therapeutics
adaptive biotechnologies
aducanumab
alicrocumab
alzheimer's disease
amblyotech
american academy of neu
american academy of neurology
What
bio
biogen
2
×
ipo
2
×
roundup
activity
america
approvals
clamped
continues
convoluted
covid
delays
democrats
developing
dreams
economic
fast
fda
head
headaches
healthcare
holding
including
insurance
isn’t
lot
medicines
moves
new
oric’s
previews
private
public
scrutiny
showing
spine
spread
suffer
testing
week
Language
unset
Current search:
ipo
×
biogen
×
" national blog main "
×
" wisconsin top stories "
×
" texas top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More